science behind semaglutide SkinnyRx Weekend Reads | The Science

Formerly known as polycystic ovarian syndrome, or PCOS, this hormonal condition is characterized by insulin resistance, weight gain, high testosterone levels, and irregular or absent periods

Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data

Retatrutide, the newest type of weight-loss drug, helped people lose an average of 70 pounds or about 30% of their body weight over 80 weeks, according to study data from the drugs manufacturer

You are out of your routine

In clinical trials, tirzepatide 15 mg produced roughly twice the weight loss of semaglutide 1 mg, and the SURMOUNT-5 trial directly compared tirzepatide to semaglutide 2.4 mg for obesity, showing tirzepatide superiority